Research coauthored by RTI Health Solutions researchers will be presented at the 2019 World Conference on Lung Cancer.
Genetic testing patterns, treatment characteristics, and overall survival in ALK-positive metastatic NSCLC patients treated with Ceritinib.
Mazieres J, Ahn MJ, Chouaid C, Kron A, Wolf J, Goyal RK, Davis KL, Perrinjaquet M, Pham T, Knoll S.
P1.16 - Treatment in the Real World - Support, Survivorship, Systems Research
Poster Viewing in the Exhibit Hall
Sep 8, 2019: Exhibit Hall, 09:45 - 18:00